118 related articles for article (PubMed ID: 71338)
1. Studies of cellular sensitization to myelin antigens in multiple sclerosis. Dissociation of MIF and LBT production in response to a peptide encephalitogenic in rhesus monkeys.
Colby-Germinario SP; Sheremata W; Bain B; Eylar EH
J Neurol Sci; 1977 Aug; 33(1-2):111-29. PubMed ID: 71338
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis: sensitization of a myelin basic protein fragment (peptide T) encephalitogenic to primates. A preliminary report.
Sheremata W; Eylar EH; Cosgrove JB
J Neurol Sci; 1977 Jun; 32(2):255-63. PubMed ID: 69018
[TBL] [Abstract][Full Text] [Related]
3. Cellular and humoral responses to myelin basic protein in multiple sclerosis: a dichotomy.
Sheremata W; Woods DD; Moscarello MA
Adv Exp Med Biol; 1978; 100():501-11. PubMed ID: 80948
[TBL] [Abstract][Full Text] [Related]
4. Cellular hypersensitivity to basic myelin (A1) protein and clinical multiple sclerosis.
Sheremata W; Cosgrove JB; Eylar EH
N Engl J Med; 1974 Jul; 291(1):14-7. PubMed ID: 4598923
[No Abstract] [Full Text] [Related]
5. Lymphocyte sensitization to basic protein of brain in multiple sclerosis and other neurological diseases.
Caspary EA; Field EJ
J Neurol Neurosurg Psychiatry; 1974 Jun; 37(6):701-3. PubMed ID: 4135820
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated cytotoxicity by peripheral blood lymphocytes against basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides in multiple sclerosis.
Frick E
J Neurol Sci; 1982; 57(1):55-66. PubMed ID: 6185643
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis-lymphocyte transformation with multiple sclerosis and normal brain myelin basic protein and subcellular fractions.
Hughes RA; Gray IA; Gregson NA; Metcalfe RA
Acta Neurol Scand; 1982 Mar; 65(3):161-73. PubMed ID: 6177188
[TBL] [Abstract][Full Text] [Related]
8. Regulation of autosensitisation to encephalitogenic myelin basic protein by macrophage-association and soluble antigen.
Steinman L; Cohen IR; Teitelbaum D; Arnon R
Nature; 1977 Jan; 265(5590):173-5. PubMed ID: 64932
[No Abstract] [Full Text] [Related]
9. Specificity of antibody-dependent lymphocyte cytotoxicity against cerebral tissue constituents in multiple sclerosis. Studies with basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides.
Frick E; Stickl H
Acta Neurol Scand; 1982 Jan; 65(1):30-7. PubMed ID: 6175158
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte transformation in the presence of myelin basic protein in multiple sclerosis and control subjects.
Hughes RA; Gray IA; Clifford-Jones R; Stern MA
Acta Neurol Scand; 1979 Aug; 60(2):65-76. PubMed ID: 91302
[TBL] [Abstract][Full Text] [Related]
11. Cellular hypersensitivity to gangliosides and myelin basic protein in multiple sclerosis.
Ilyas AA; Davison AN
J Neurol Sci; 1983 Apr; 59(1):85-95. PubMed ID: 6189970
[TBL] [Abstract][Full Text] [Related]
12. Optic neuritis and multiple sclerosis. Cell-mediated cytotoxicity by peripheral blood lymphocytes against basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides.
Frick E
Eur Neurol; 1988; 28(3):120-5. PubMed ID: 2454817
[TBL] [Abstract][Full Text] [Related]
13. Cellular hypersensitivity in attacks of multiple sclerosis. I. A comparative study of migration inhibitory factor production and lymphoblastic transformation in response to myelin basic protein in multiple sclerosis.
Colby SP; Sheremata W; Bain B; Eylar EH
Neurology; 1977 Feb; 27(2):132-9. PubMed ID: 556829
[TBL] [Abstract][Full Text] [Related]
14. Cellular hypersensitivity to basic myelin (P2) protein in the Guillain-Barré syndrome.
Sheremata W; Colby S; Karkhanis Y; Eylar EH
Can J Neurol Sci; 1975 May; 2(2):87-90. PubMed ID: 165869
[TBL] [Abstract][Full Text] [Related]
15. Dissociation of MIF activity and in vitro lymphocyte transformation in the development of experimental allergic thyroiditis in guinea pigs.
Hiramine C; Hojo K
Tohoku J Exp Med; 1976 Feb; 118(2):137-43. PubMed ID: 790649
[TBL] [Abstract][Full Text] [Related]
16. Suppressed lymphoblastic response to myelin basic protein of lymphocytes from patients with multiple sclerosis.
Wicher V; Olszewski W; Milgrom F
Int Arch Allergy Appl Immunol; 1979; 59(1):49-57. PubMed ID: 87376
[No Abstract] [Full Text] [Related]
17. Sensitization to myelin basic protein in attacks of multiple sclerosis. A preliminary report.
Sheremata W; Wood DD; Moscarello AA; Cosgrove JB
J Neurol Sci; 1978 Apr; 36(2):165-70. PubMed ID: 206672
[TBL] [Abstract][Full Text] [Related]
18. The T-lymphocyte response against myelin-associated glycoprotein and myelin basic protein in patients with multiple sclerosis.
Zhang Y; Burger D; Saruhan G; Jeannet M; Steck AJ
Neurology; 1993 Feb; 43(2):403-7. PubMed ID: 7679782
[TBL] [Abstract][Full Text] [Related]
19. Subacute sclerosing panencephalitis and multiple sclerosis: in vitro measles immunity and sensitization to myelin basic protein.
Sheremata W; Sazant A; Watters G
Can Med Assoc J; 1978 Mar; 118(5):509-13. PubMed ID: 343902
[TBL] [Abstract][Full Text] [Related]
20. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.
Kerlero de Rosbo N; Milo R; Lees MB; Burger D; Bernard CC; Ben-Nun A
J Clin Invest; 1993 Dec; 92(6):2602-8. PubMed ID: 7504688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
